These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 14647335)

  • 1. The patent gamble: strategic insights for playing the worldwide patent game.
    Barrett WA
    Nat Biotechnol; 2003 Dec; 21(12):1515-7. PubMed ID: 14647335
    [No Abstract]   [Full Text] [Related]  

  • 2. Biotechs for pennies?
    Jacobs T
    Nat Biotechnol; 2004 Dec; 22(12):1509. PubMed ID: 15583652
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotechs sue Columbia over fourth Axel patent.
    Howard K
    Nat Biotechnol; 2003 Sep; 21(9):955-6. PubMed ID: 12949538
    [No Abstract]   [Full Text] [Related]  

  • 4. International patent filing. Factors to consider in deciding when and where to file outside the United States.
    Agris CH
    Nat Biotechnol; 1998 May; 16(5):479-80. PubMed ID: 9592399
    [No Abstract]   [Full Text] [Related]  

  • 5. Ownership at too high a price?
    Nat Biotechnol; 2003 Sep; 21(9):953. PubMed ID: 12949537
    [No Abstract]   [Full Text] [Related]  

  • 6. The margin of safety.
    Jacobs T
    Nat Biotechnol; 2002 Dec; 20(12):1191. PubMed ID: 12454663
    [No Abstract]   [Full Text] [Related]  

  • 7. Napster case spills into biotech sector.
    Bouchie A
    Nat Biotechnol; 2004 Sep; 22(9):1185-6. PubMed ID: 15384189
    [No Abstract]   [Full Text] [Related]  

  • 8. US Patent Office strategic plan may penalize biotechs.
    Robertson D
    Nat Biotechnol; 2003 Apr; 21(4):345-6. PubMed ID: 12665807
    [No Abstract]   [Full Text] [Related]  

  • 9. Kenyan dispute illuminates bioprospecting difficulties.
    Sheridan C
    Nat Biotechnol; 2004 Nov; 22(11):1337. PubMed ID: 15529141
    [No Abstract]   [Full Text] [Related]  

  • 10. Profit and the patent on life.
    Attali J
    New Perspect Q; 1994; 11(1):12-5. PubMed ID: 15739292
    [No Abstract]   [Full Text] [Related]  

  • 11. Brand: a company's most valuable asset.
    Carter S
    Med Device Technol; 2004 Jun; 15(5):11. PubMed ID: 15285479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equivalents in biotechnology patents.
    Auer HE
    Nat Biotechnol; 2003 Mar; 21(3):329-31. PubMed ID: 12610574
    [No Abstract]   [Full Text] [Related]  

  • 13. Patenting the parts.
    Nat Biotechnol; 2007 Aug; 25(8):822. PubMed ID: 17687343
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent patent applications in tissue engineering.
    Nat Biotechnol; 2006 Sep; 24(9):1095. PubMed ID: 16964216
    [No Abstract]   [Full Text] [Related]  

  • 15. No pain, no gain?
    Jacobs T
    Nat Biotechnol; 2005 Aug; 23(8):934. PubMed ID: 16082357
    [No Abstract]   [Full Text] [Related]  

  • 16. Brussels takes EU states to court over biopatent law.
    Habeck M
    Nat Biotechnol; 2003 Sep; 21(9):960. PubMed ID: 12949544
    [No Abstract]   [Full Text] [Related]  

  • 17. EPO neem patent revocation revives biopiracy debate.
    Sheridan C
    Nat Biotechnol; 2005 May; 23(5):511-2. PubMed ID: 15877054
    [No Abstract]   [Full Text] [Related]  

  • 18. Patenting pluripotence: the next battle for stem cell intellectual property.
    Vrtovec KT; Scott CT
    Nat Biotechnol; 2008 Apr; 26(4):393-5. PubMed ID: 18392018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent pools and standard setting in diagnostic genetics.
    Ebersole TJ; Guthrie MC; Goldstein JA
    Nat Biotechnol; 2005 Aug; 23(8):937-8. PubMed ID: 16082359
    [No Abstract]   [Full Text] [Related]  

  • 20. The coming US patent opposition.
    Apple T
    Nat Biotechnol; 2005 Feb; 23(2):245-7. PubMed ID: 15696151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.